Senior Director, Search & Evaluation Late TA Lead, Immunology

ppCSL is expanding its external innovation capability, and we're looking for a Senior Director of Search Evaluation to help shape the future of our Immunology portfolio. /p pWe are seeking a bSenior Director of Search Evaluation /b to lead strategic sourcing and evaluation of later-stage external clinical assets in bImmunology /b. This leader will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions. /p pTo be hybrid-based onsite (3 days a week) at one of our RD hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely /p h3Main Responsibilities Accountabilities /h3 ul lipServe as the senior SE leader within the Therapy Area Leadership Team, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning. /p /li lipLead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs. /p /li lipCo-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Immunology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations. /p /li lipEngage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs clinical endpoints, and anticipate competitive dynamics. /p /li lipMaintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy. /p /li lipDrive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions. /p /li lipPartner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution /p /li lipRepresent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities. /p /li /ul h3Qualifications Experience Requirements /h3 ul lip15+ years in biopharma with significant experience in clinical development, external innovation, or business development. /p /li lipAdvanced degree required (MD, PhD, or equivalent). /p /li lipDeep clinical expertise in Immunology /p /li lipProven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks. /p /li lipStrong understanding of regulatory pathways, market access, and competitive standards of care. /p /li /ul /p #J-18808-Ljbffr